The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Postprandial Hyperglycemia and Diabetes Complications
Abstract
Increasing evidence suggests that the postprandial state is a contributing factor to the development of atherosclerosis. In diabetes, the postprandial phase is characterized by a rapid and large increase in blood glucose levels, and the possibility that the postprandial “hyperglycemic spikes” may be relevant to the onset of cardiovascular complications has recently received much attention. Epidemiological studies and preliminary intervention studies have shown that postprandial hyperglycemia is a direct and independent risk factor for cardiovascular disease (CVD). Most of the cardiovascular risk factors are modified in the postprandial phase in diabetic subjects and directly affected by an acute increase of glycemia. The mechanisms through which acute hyperglycemia exerts its effects may be identified in the production of free radicals. This alarmingly suggestive body of evidence for a harmful effect of postprandial hyperglycemia on diabetes complications has been sufficient to influence guidelines from key professional scientific societies. Correcting the postprandial hyperglycemia may form part of the strategy for the prevention and management of CVDs in diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Postprandial hyperglycemia can impact microand macro-vascular complications of diabetes more than elevated fasting glucose levels, making adequate glucose control after meals beneficial.”
From The Impact of Physical Activity in Patients With Type 2 Diabetes (2025) · cites this paper as [91]
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
De Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187 · cited 1×
“As far as infarction is concerned, it has been recently demonstrated by a metaanalysis that there is a continuous correlation between glucose serum levels and the seriousness of the prognosis even in nondiabetic subjects (22), while intensive insulin treatment during acute myocardial infarction reduces long-term morta…”
BackgroundEsposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · cited 1×
“Studies support the evidence that an acute hyperglycemia during a hyperglycemic clamp (56) or in the postprandial state (57) can increase the production of plasma interleukin-6, tumor necrosis factor- , and interleukin-18.”
BackgroundSelf-citation
Cited by
Sorted by citations
Items 701–800 of 951
Functional Food Components for Preventing and Combating Type 2 Diabetes
Sarkar, D., Ankolekar, C., & Shetty, K. (2012) · ACS symposium series · doi:10.1021/bk-2012-1093.ch020 · Cited by 5
Colomo, N., López‐Siguero, J. P., Leiva, I., Fuentes, N., Rubio‐Martín, E., Omiste, A., Guerrero, M., Tapia, M. J., Tejedor, B. M., de Adana, M. S. R., et al. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.10.003 · Cited by 5
Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?
Monnier, L. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0454 · Cited by 5
Deguchi, S., Ogata, F., Isaka, T., Otake, H., Nakazawa, Y., Kawasaki, N., & Nagai, N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030375 · Cited by 4
Konić‐Ristić, A., Ryan, S., Attjioui, M., O’Connell, S., & Gibney, E. R. (2023) · Marine Drugs · doi:10.3390/md21060337 · Cited by 4
Trawley, S. L., Kwon, H. J., Vogrin, S., Colman, P. G., Fourlanos, S., Lee, M. H., MacIsaac, R. J., O'Neal, D. N., O’Regan, N., Sundararajan, V., et al. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0303 · Cited by 4
Bravo-García, A. P., Radford, B. E., Hall, R. C., Broome, S. C., Tee, N., Arthur, B., Janssens, K., Johnston, R. D., Halson, S. L., Devlin, B. L., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112081 · Cited by 10
Gerő, L., Gyimesi, A., Hídvégi, T., & Jánosi, I. (2009) · Orvosi Hetilap · doi:10.1556/oh.2009.28705 · Cited by 4
Hypertension, diabetes, insulin resistance, and postprandial hyperglycemia
Bell, D. S. H. (2006) · Drug Development Research · doi:10.1002/ddr.20130 · Cited by 4
Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients
Perticone, M., Tassone, E. J., Scarpino, P. E., Naccarato, P., Addesi, D., Cello, S. D., Sciacqua, A., Maio, R., Andreucci, M., Corrao, S., et al. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0740-1 · Cited by 4
Glycemic Variability and Type 2 Diabetes Mellitus
Gribovschi, M., ŢIGAN, Ş. “. H. U. O. M. A. P., & HÂNCU, N. “. M. C. (2013) · Applied Medical Informatics (University of Medicine and Pharmacy Cluj-Napoca) · Cited by 4
Li, Z., Hu, Y., & Ma, J. (2018) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-4254.2018.10.03 · Cited by 4
Brunetti, V. C., Yu, O. H. Y., Platt, R. W., & Filion, K. B. (2021) · Diabetic Medicine · doi:10.1111/dme.14603 · Cited by 4
Raghavan, V. A., & Garber, A. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_7 · Cited by 4
Maladie rénale chronique et diabète de type 2. Histologie, pathogénie et stades évolutifs
Monnier, L., Halimi, S., & Colette, C. (2023) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2023.10.003 · Cited by 4
Kim, J. Y., Kwon, H. Y., Kim, K. S., Kim, M.-K., & Kwon, O. (2013) · Journal of Medicinal Food · doi:10.1089/jmf.2013.2781 · Cited by 4
Bhoite, R. (2020) · Journal of Diabetes & Metabolism · doi:10.35248/2155-6156.20.11.841 · Cited by 4
Dimić, D., Velojić-Golubović, M., Antić, S., & Radenković, S. (2009) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657205 · Cited by 4
Optimal insulin treatment for patients with type 2 diabetes
Jermendy, G. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.009 · Cited by 4
Samad, M. B., Hasan, M. N., Banarjee, S., Rahman, M. M., Raihan, S., Banti, F. L., Sayfe, S. S., Hasan, S. M. N., Akhter, F., Kabir, A. U., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.113 · Cited by 4
Mbagwu, I. S., Akah, P. A., Ajaghaku, A. A., Ugwu, O. C., & Ajaghaku, D. L. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100023 · Cited by 4
mRNA Translation in Diabetic Nephropathy
Kasinath, B. S., Lee, M. J., Féliers, D., & Sonenberg, N. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-153-6_6 · Cited by 4
Dysglycemia and Cardiovascular Risk
Nonogaki, K. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.078 · Cited by 4
Ogawa, R., Sugimoto, C., Hamada, A., Ninomiya, K., Ina, S., Yamaguchi, Y., Kumagai, H., & Kumagaı, H. (2023) · Sustainable Food Proteins · doi:10.1002/sfp2.1006 · Cited by 3
Ravi, L., Venkatesh, S., Jain, P., R, S. K. G., Vaithilingam, M., Manjunathan, R., Ajith Kumar, K., & Kesavan, M. P. (2024) · In Silico Pharmacology · doi:10.1007/s40203-024-00257-6 · Cited by 3
Mohammed, M. E. A., Fadlallah, E. M. A., & Mohamed, A. (2014) · Cited by 3
HbA1c: the case for using estimated average glucose (eAG)
Home, P. D. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02516.x · Cited by 3
Matyjaszek‐Matuszek, B., Lenart-Lipińska, M., Rogalska, D., Nowakowski, A. M., & GWAA Polish Study Group (2013) · Endokrynologia Polska · doi:10.5603/ep.2013.0021 · Cited by 3
Chitosan and Its Derivatives for Treatment of Diabetic Complications
Kim, S., & Karadeniz, F. (2012) · CRC Press eBooks · doi:10.1201/b13868-17 · Cited by 3
Qiu, J.-Y., Li, C., Dong, Z., & Wang, J. (2020) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v19i6.20 · Cited by 3
Chun, E., Gaynanova, I., Melanson, E. L., & Lyden, K. A. (2024) · Journal for the Measurement of Physical Behaviour · doi:10.1123/jmpb.2023-0032 · Cited by 3
Verbovoy, A. F., Владимировна, П. А., Verbovaya, N. I., Madyanov, I. V., Sharonova, L. A., & Galkin, R. A. (2018) · Terapevticheskii arkhiv · doi:10.26442/terarkh2018908113-117 · Cited by 3
Park, J.-E., Lee, J., & Han, J.-S. (2017) · Europe PMC (PubMed Central) · doi:10.3746/pnf.2017.22.3.166 · Cited by 3
La variabilité glycémique : un facteur de risque singulier à conjuguer au pluriel
Monnier, L., Colette, C., Bonnet, F., & Owens, D. R. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.11.003 · Cited by 3
Prevention of Diabetes Complications
Soltani, N. (2011) · InTech eBooks · doi:10.5772/24324 · Cited by 3
Insulin and New Insulin Analogues with Focus on Type 2 Diabetes
Madsbad, S. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_7 · Cited by 3
Postprandial intradialytic dysglycaemia and diabetes in maintenance haemodialysis patients
Haider, D. G., Fuhrmann, H., Kovařík, J., Heiss, S., Graf, H., Auinger, M., Mittermayer, F., Wolzt, M., & Hörl, W. H. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02012.x · Cited by 3
Quo vadisnateglinide? Ten-year perspective
Grunberger, G. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.600305 · Cited by 3
Rafiq, M., Sancheti, S., Sancheti, E. A., Kim, H.-R., You, Y., & Seo, S. (2013) · Journal of Medicinal Plants Research · doi:10.5897/jmpr12.071 · Cited by 3
Urine Albumin Excretion as a Marker of Acute Glycemic Changes in Isolated Postprandial Hyperglycemia
Shilpasree, A. S., Patil, V. S., Patil, V. P., & Ingleshwar, D. G. (2016) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.187925 · Cited by 3
Sharma, H. S. S., & Kumar, S. (2016) · Journal of Pharmacognosy and Phytochemistry · Cited by 3
Preclinical Study of the Antidiabetic Effect of Traganum nudatum in Diabetic Rats
El-Ouady, F., & Eddouks, M. (2020) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/1871525718666200228113239 · Cited by 3
Oh, T. J. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.4.233 · Cited by 3
Klupa, T., Malecki, M. T., & Sieradzki, J. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200330 · Cited by 3
Glucose metabolism after pancreas-kidney transplantation
Diakoff, E. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0055-5 · Cited by 3
Diabetes as a Disease of Aging, and the Role of Oxidative Stress
Sarkar, D., & Shetty, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405933-7.00006-8 · Cited by 3
Pujangga, I. W., Nainggolan, D., & Thadeus, M. S. (2019) · Jurnal Gizi dan Pangan · doi:10.25182/jgp.2019.14.3.157-164 · Cited by 3
Personalizing dietary interventions by predicting individual vulnerability to glucose excursionsPreprint
Brügger, V., Kowatsch, T., & Jovanova, M. (2024) · medRxiv · doi:10.1101/2024.08.07.24311591 · Cited by 3
Chiu, H., Golovinskaia, O., Tandoro, Y., Wang, L., & Wang, C. (2024) · eFood · doi:10.1002/efd2.176 · Cited by 2
Kong, X., & Qiu, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-01773-x · Cited by 3
Kinny, F., Läer, S., & Obarčanin, E. (2025) · PLOS Digital Health · doi:10.1371/journal.pdig.0001087 · Cited by 2
Heydari‐Zarnagh, H., Shookohi, A. N., & Nourozi, A. (2014) · Zahedan Journal of Research in Medical Sciences · Cited by 2
Laser-acupuntura no controle da glicemia na Diabetes tipo II: ensaio clínico randomizado
Pereira, C. D., Alvim, N. A. T., Pereira, R. D. D. M., Bergold, L. B., Gomes, S. C., & Bastos, V. D. (2021) · Enfermería Global · doi:10.6018/eglobal.443241 · Cited by 2
Larsen, E. L., Kjær, L. K., Lundby‐Christensen, L., Boesgaard, T. W., Breum, L., Gluud, C. N., Hedetoft, C., Krarup, T., Lund, S. S., Mathiesen, E. R., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.028 · Cited by 2
Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7380-0_5 · Cited by 2
Agosto, N. J. (2024) · Journal of the Serbian Chemical Society · doi:10.2298/jsc240923104a · Cited by 2
Kumari, A., Pakyntein, C. L., Nongrum, S., Thabah, D., Sunn, S. E., & Syiem, D. (2025) · International Journal of Plant Based Pharmaceuticals · doi:10.62313/ijpbp.2025.244 · Cited by 2
HbA1c Variability and Cardiovascular Events
Mehring, M., Donnachie, E., & Schneider, A. (2016) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-016-0501-x · Cited by 2
Rehman, A.-U., Latif, A., Anwar, R., Abbas, N. A., Nawaz, S., & Mirza, H. T. (2019) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/2019.51.1.333.340 · Cited by 2
Fluorescence Biosensors for Continuously Monitoring the Blood Glucose Level of Diabetic Patients
D’Auria, S., Ghirlanda, G., Parracino, A., de Champdoré, M., Scognamiglio, V., Staiano, M., & Rossi, M. (2006) · Springer eBooks · doi:10.1007/0-387-33015-1_5 · Cited by 2
Periodontitis and Diabetes Mellitus
Straka, M., & Trapezanlidis, M. (2012) · InTech eBooks · doi:10.5772/50269 · Cited by 2
Chacon, M. T. R., Lopez-Arellanes, L. R., & Flores-Padilla, L. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Glycaemic Control and Protection of the Vasculature from Glucose Toxicity
Ding, H., & Chris, R. B. (2011) · InTech eBooks · doi:10.5772/24862 · Cited by 2
Improving glycemic control and cardiometabolic risk through integrated treatment plans.
Lavernia, F. (2010) · PubMed · Cited by 2
Safety and side effects of the insulin analogues
Bain, S. C., & Kamal, A. D. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.3.349 · Cited by 2
Han, H., Corbin, R., Godfrey, C. M., Leung, L., Chen, J., Lee, M. S., Zhang, T., & Feng, L. (2013) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2013-727 · Cited by 2
Iizuka, K., Tomita, R., Horikawa, Y., & Takeda, J. (2012) · Diabetology International · doi:10.1007/s13340-012-0068-9 · Cited by 2
Importance of hereditary haemochromatosis in the care of diabetes mellitus
Wittmann, I., Wagner, L. J., Markó, L., Tamaskó, M., Laczy, B., Mohás, M., Cseh, J., & Melegh, B. (2007) · Orvosi Hetilap · doi:10.1556/oh.2007.27901 · Cited by 2
CORRELATES OF THE DIURNAL PLASMA GLUCOSE VARIABILITY IN NON-INSULIN-TREATED TYPE 2 DIABETIC PATIENTS
Bradescu, O. M., Ionescu-Tirgoviste, C., & Paulescu, N. (2008) · Cited by 2
Choe, C. H., & Edelman, S. V. (2007) · Southern Medical Journal · doi:10.1097/01.smj.0000286751.78656.45 · Cited by 2
- Treatment of Obesity and Diabetes with Marine-Derived Biomaterials
Kim, S., Karadeniz, F., & Karagozlu, M. Z. (2013) · CRC Press eBooks · doi:10.1201/b14723-26 · Cited by 2
Variability in Insulin Action: Mechanisms, Implications, and Recent Advances
(2007) · The Internet Journal of Family Practice · doi:10.5580/173f · Cited by 2
Nygaard, H., Slettaløkken, G., Whist, J. E., Hollan, I., Ellefsen, S., Holmboe‐Ottesen, G., Rønnestad, B. R., & Høstmark, A. T. (2017) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3576-2 · Cited by 2
Effects of reduced β2 glycoprotein I on high glucose-induced cell death in HUVECs
Zhang, J.-Y., Ma, J., Yu, P., Tang, G.-J., Li, C., Yu, D. M., & Zhang, Q.-M. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7065 · Cited by 2
Modern strategies for self-monitoring: new era of effective diabetes management
Svetlova, O. V., Владимировна, Г. И., & Savchenko, L. S. (2019) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-4-30-33 · Cited by 2
Bhosale, A., Krishna, M., Das, S., & Gautam, M. (2017) · The Journal of Medical Sciences · doi:10.5005/jp-journals-10045-0048 · Cited by 2
(2010) · Elsevier eBooks · doi:10.1016/b978-2-294-70868-8.50004-9 · Cited by 2
Diabetic Mellitus and it’s complications in Duhok city/ IRAQ
Ali, A. A. (2012) · Journal of education for pure science. · Cited by 2
Evaluation of walking exercise on glycemic control in patients with type 2 diabetes mellitus
Hu, H., Lei, Y., Yin, L., & Luo, X. (2020) · Medicine · doi:10.1097/md.0000000000022735 · Cited by 4
Goldberg, R. B. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.006 · Cited by 2
Chang, C. R., Astell‐Burt, T., Russell, B. M., & François, M. E. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057183 · Cited by 2
Zagury, R., Lacativa, P. G. S., de Gregório, L. H., Rosenfeld, V. A. S., Campos, L. F., Pinheiro, R. A. C., da Costa, S. F., & Russo, L. A. T. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.04204 · Cited by 2
Jafari, M., Ghasemi-Soloklui, A. A., & Kordrostami, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300615 · Cited by 2
Pathogenesis of the Metabolic Syndrome
Tobe, K., Yamauchi, T., Kubota, N., Hara, K., Ueki, K., & Kadowaki, T. (2007) · Springer eBooks · doi:10.1007/978-1-84628-911-8_3 · Cited by 2
Management of cardiovascular risk at patients with a diabetes mellitus type 2.
Владимировна, П. А., Verbovoy, A. F., Galkin, R. A., Verbovaya, N. I., Sharonova, L. A., & Dolgikh, Y. A. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2018-96-8-696-701 · Cited by 2
Arimura, T., Watanabe, S., Sakakibara, H., & Kimura, S. (2021) · Acta Scientifci Nutritional Health · doi:10.31080/asnh.2020.05.0881 · Cited by 1
Rousset, M. (2015) · Diabetes & Metabolism · doi:10.1016/s1262-3636(15)30188-9 · Cited by 2
Considering Pramlintide Therapy for Postprandial Blood Glucose Control
Childs, B. P., Kesty, N. C., KLEIN, E. J., Rubin, R. R., & Wick, A. (2007) · Diabetes Spectrum · doi:10.2337/diaspect.20.2.108 · Cited by 2
In vitro investigation of the inhibitory effect of fucoidan on ɑ-glucoisidase enzyme activity
Yin, X. (2013) · UTAS Research Repository · Cited by 2
Needle‐Free Jet Injectors for Dermal and Transdermal Delivery of Actives
Schlich, M., Primavera, R., Lai, F., Sinico, C., & Decuzzi, P. (2019) · doi:10.1002/9783527814633.ch9 · Cited by 2
Davies, M. J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01833h.x · Cited by 2
Konić‐Ristić, A., Ryan, S., Attjioui, M., O’Connell, S., & Gibney, E. R. (2023) · Preprints.org · doi:10.20944/preprints202305.0187.v1 · Cited by 1
Lagarto, A., Sánchez, E., Piloto, J., Remigio, A. C., Barzaga, P., Rodríguez, C., Carballo, C., Couret, M., Vega, Y., & López, R. (2014) · Revista Brasileira de Plantas Medicinais · doi:10.1590/1983-084x/11_099 · Cited by 1
Rakipovski, G., Lykkesfeldt, J., & Raun, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147412 · Cited by 1
Navarro‐Tapia, E., Chenoll, E., Rueda, J. M. W., & Ramón, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00105-4 · Cited by 1
Glycemic Index of a High Protein and High Fiber Oral Nutritional Supplement Vidaslim®
Gayathri, R., Parkav, K., Kavitha, V., Gayathri, N., Jeevan, R. G., Shobana, S., Sudha, V., Ranjit Unnikrishnan, I., Anjana, R. M., Mohan, V., et al. (2023) · Medical Research Archives · doi:10.18103/mra.v11i3.3576 · Cited by 1
Hatakeyama, N., Sakurai, T., Ohto-Fujita, E., Atomi, T., Shimizu, M., & Atomi, Y. (2024) · Journal of Fiber Science and Technology · doi:10.2115/fiberst.2024-0004 · Cited by 1
Nutrition Therapy for Adults with Type 1 and Insulin-Requiring Type 2 Diabetes
Evert, A. B. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580406482.ch06 · Cited by 1
Mucus Barrier Weakens the Inhibitory Activity of Pyrogallol‐Based Polyphenols Against α‐Glucosidase
Wáng, Y., Lan, S., Zhang, L., Li, Y., Deng, Z., Ye, X., Pan, H., & Chen, S. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400838 · Cited by 1
Bangshaab, M., Bengtsen, M. B., Smedegaard, S. B., Søndergaard, E., Møller, N., Svart, M. V., & Rittig, N. F. (2025) · Diabetologia · doi:10.1007/s00125-025-06614-0 · Cited by 1
Metadata
- Authors
- Ceriello, A.
- Affiliations
- University of Udine (IT)
- Corresponding author
- Ceriello, Antonio
- ORCID
- Ceriello, Antonio
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-01-01
- Volume
- 54
- Issue
- 1
- Pages
- 1-7
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2120704605
- Cited by
- 945
- References
- 95
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 29 · 2023: 30 · 2022: 34 · 2021: 46 · 2020: 43 · 2019: 46 · 2018: 49 · 2017: 51 · 2016: 43 · 2015: 45 · 2014: 43 · 2013: 71 · 2012: 43
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- postprandial hyperglycemia, diabetes complications, cardiovascular risk, atherosclerosis, free radicals, oxidative stress, cardiovascular risk factors, diabetes management
- MeSH terms
- Arteriosclerosis, Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetic Angiopathies, DNA Damage, Humans, Hyperglycemia, Models, Biological, Oxidative Stress, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review